Image guided therapies including percutaneous tumor ablation, chemoembolization, small particle embolization and radio-embolization are available and can prolong tumor control in the liver. More RCT/registries are needed to prove value
A trial to test the combined of the two drugs itraconazole (a generic drug to treat fungal infections) and pemetrexed to treat NSCLC in the second line setting.
MicroRNAs and lncRNAs are non-coding RNAs found as oncogenes, tumor suppressor genes or key players in cancer. Differentially expressed in tumors versus normal cells, they show correlation with diagnosis, staging, progression and prognosis.
I have created a system for the creation of nutritionally dense foods for patients with swallowing disorders due to cancer treatments such as chemotherapy and surgery. I am an author and journalist and have interviewed healthcare professionals.
A primary investigator has little to no formal training on how to manage money, people, or a laboratory, yet the funding institutions have no problem giving them large sums of tax payer money to use as they see fit. Better business skills are needed.
small RNA cancer therapeutics have the ability to target multiple oncogenic pathways simultaneously. This approach could be the perfect antidote to the plethora of heterogeneous driver mutations in cancer & subsequent development of drug resistance.
At times, surgery is not an option to remove tumors. We would like to suggest a new tool to kill tumors without affecting healthy tissue, and without invasive surgery.
The method describes how to focus an external source of heating only on the tumor.
test the thousands of substances, foods,chemicals and/or additives for carcinogens.
Expanding the individual pool provides great opportunities for success and gained from incorporating clinicians abroad. Active attempts to seek out primarily physician-types, offering them green card or other visas to the U.S. would greatly help.
An ex vivo technique that tests a patient's own cancer cells against a large panel of drugs and drug combinations in order to determine the best therapy.
ASCO is pleased to submit this Cancer Moonshot idea: Dissemination and Implementation Research on Cancer Care Delivery. Please see the attached document for a more detailed proposal.
Cancerogenesis not genetic issue. It cytoplasmic issue. Described photo biologic pathway of mitosis triggering. Shown damage in this pathway, leading to cancerigenesis. Have full pathway from nutrition to cell, can say who will acquire cancer.
ASCO is pleased to submit this Cancer Moonshot idea: Patient-Reported Outcomes for Measuring Effectiveness and Harms of Cancer Treatments.
ASCO is pleased to submit this Cancer Moonshot idea: Research to Guide Effective Survivorship Care.
It is estimated that 50 to 100% of cancers harbor mutations in the tumor suppressor gene TP53. Here we propose designing a virus that replicates in cells with dysfunctional TP53.